CGON vs VRTX: Which Stock is Better?

Side-by-side comparison of Cg Oncology Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

CGON

Cg Oncology Inc

$68.68

VRTX

Vertex Pharmaceuticals Inc

$430.29

Key Metrics Comparison

MetricCGONVRTXWinner
Market Cap$5.90B$110.67BVRTX
P/E RatioN/A28.40VRTX
EPS (TTM)$N/A$15.32VRTX
Revenue Growth4.1%0.1%CGON
Gross Margin-2902.2%53.7%VRTX

Analyze CGON

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGON or VRTX a better investment?

Comparing CGON and VRTX: Cg Oncology Inc has a market cap of $5.90B while Vertex Pharmaceuticals Inc has $110.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGON and VRTX?

CGON (Cg Oncology Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGON or VRTX?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGON or VRTX?

CGON has higher revenue growth at 4.1% vs 0.1% for VRTX.

Which company is more profitable: CGON or VRTX?

Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -2902.2% for CGON.

Which is the larger company: CGON or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.67B compared to $5.90B for CGON.

Should I buy CGON or VRTX in 2026?

Both CGON and VRTX have investment merit. CGON trades at $68.68 while VRTX trades at $430.29. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGON and VRTX stock?

Key differences: Market Cap ($5.90B vs $110.67B), P/E Ratio (N/A vs 28.4x), Revenue Growth (4.1% vs 0.1%), Gross Margin (-2902.2% vs 53.7%).

Popular Stock Comparisons